Abstract
Two decades after the first bacterial genome sequencing by Fleischmann et al. in 1995, bacterial genomics gained an important role both in the identification and antimicrobial susceptibility testing of bacterial pathogens. Continuous advances in high throughput sequencing (Next Generation Sequencing, NGS) technologies have empowered today’s clinical microbiology laboratory with vast potential in pathogen detection, identification and characterisation. Bacterial whole-genome sequencing (WGS) is the most promising aspect of these technologies. Most clinical microbiology laboratories are not currently ready to adopt and implement WGS in their routine, mostly because of costs, time to results and data interpretation issues and it is currently applied in specific niches, such as molecular epidemiology and outbreak investigations, as well as identification and susceptibility testing of difficult-to-grow yet clinically important pathogens, such as Mycobacterium tuberculosis. In this chapter, the application of WGS in the routine clinical microbiology laboratories for identification and susceptibility testing of common and fastidious bacteria will be discussed with specific emphasis on mycobacteria as an example of utilisation of NGS technologies on clinically important slow-growing pathogens.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Rossen JWA, Friedrich AW, Moran-Gilad J (2018) Practical issues in implementing whole-genome-sequencing in routine diagnostic microbiology. Clin Microbiol Infect 24:355–360
Judge K, Harris SR, Reuter S, Parkhill J, Peacock SJ (2015) Early insights into the potential of the Oxford Nanopore MinION for the detection of antimicrobial resistance genes. J Antimicrob Chemother 70:2775–2778
Reuter S, Ellington MJ, Cartwright EJP et al (2014) Europe PMC Funders Group. Rapid bacterial whole-genome sequencing to enhance diagnostic and public health microbiology. JAMA Intern Med 173:1397–1404
Köser CU, Fraser LJ, Ioannou A et al (2014) Rapid single-colony whole-genome sequencing of bacterial pathogens. J Antimicrob Chemother 69:1275–1281
Cummings CA, Bormann Chung CA, Fang R et al (2010) Accurate, rapid and high-throughput detection of strain-specific polymorphisms in Bacillus anthracis and Yersinia pestis by next-generation sequencing. Investig Genet 1:1–14
Bertelli C, Greub G (2013) Rapid bacterial genome sequencing: methods and applications in clinical microbiology. Clin Microbiol Infect 19:803–813
Hasman H, Saputra D, Sicheritz-Ponten T, Lund O, Svendsen CA, Frimodt-Moller N, Aarestrup FM (2014) Rapid whole-genome sequencing for detection and characterization of microorganisms directly from clinical samples. J Clin Microbiol 52:139–146
Adey A, Morrison HG, Asan et al (2010) Rapid, low-input, low-bias construction of shotgun fragment libraries by high-density in vitro transposition. Genome Biol 11:R119
Besser J, Carleton HA, Gerner-Smidt P, Lindsey RL, Trees E (2018) Next-generation sequencing technologies and their application to the study and control of bacterial infections. Clin Microbiol Infect 24:335–341
Gargis AS, Kalman L, Berry MW et al (2013) Assuring the quality of next-generation sequencing in clinical laboratory practice. Nat Biotechnol 30(11):1033–1036. https://doi.org/10.1038/nbt.2403.Assuring
Roy S, Coldren C, Karunamurthy A et al (2018) Standards and guidelines for validating next-generation sequencing bioinformatics pipelines: a joint recommendation of the Association for Molecular Pathology and the College of American Pathologists. J Mol Diagn 20:4–27
Gargis AS, Kalman L, Bick DP et al (2015) Good laboratory practice for clinical next-generation sequencing informatics pipelines. Nat Biotechnol 33:689–693
Lefterova MI, Suarez CJ, Banaei N, Pinsky BA (2015) Next-generation sequencing for infectious disease diagnosis and management: a report of the Association for Molecular Pathology. J Mol Diagn 17:623–634
Pont-Kingdon G, Gedge F, Wooderchak-Donahue W, Schrijver I, Weck KE, Kant JA, Oglesbee D, Bayrak-Toydemir P, Lyon E (2012) Design and analytical validation of clinical DNA sequencing assays. Arch Pathol Lab Med 136:41–46
Gargis A, Kalman L, Lubin IM (2016) Assuring the quality of next-generation sequencing in clinical laboratory practice. J Clin Microbiol 54:2857–2865
Rehm HL, Bale SJ, Bayrak-toydemir P, Jonathan S, Brown KK, Deignan JL, Friez MJ, Birgit H (2013) ACMG clinical laboratory standards for next-generation sequencing. Genet Med 15:733–747
Moran-Gilad J, Sintchenko V, Pedersen SK, Wolfgang WJ, Pettengill J, Strain E, Hendriksen RS (2015) Proficiency testing for bacterial whole genome sequencing: an end-user survey of current capabilities, requirements and priorities. BMC Infect Dis 15:1–10
Long SW, Williams D, Valson C, Cantu CC, Cernoch P, Musser JM, Olsen RJ (2013) A genomic day in the life of a clinical microbiology laboratory. J Clin Microbiol 51:1272–1277
Anson LW, Chau K, Sanderson N et al (2018) DNA extraction from primary liquid blood cultures for bloodstream infection diagnosis using whole genome sequencing. J Med Microbiol 67:347–357
Clark SA, Doyle R, Lucidarme J, Borrow R, Breuer J (2018) Targeted DNA enrichment and whole genome sequencing of Neisseria meningitidis directly from clinical specimens. Int J Med Microbiol 308:256–262
Wilson MR, Naccache SN, Samayoa E et al (2014) Actionable diagnosis of neuroleptospirosis by next-generation sequencing. N Engl J Med 370:2408–2417
Seth-Smith HMB, Harris SR, Skilton RJ et al (2013) Whole-genome sequences of chlamydia trachomatis directly from clinical samples without culture. Genome Res 23:855–866
Christiansen MT, Brown AC, Kundu S et al (2014) Whole-genome enrichment and sequencing of chlamydia trachomatis directly from clinical samples. BMC Infect Dis 14:1–11
Andersson P, Klein M, Lilliebridge RA, Giffard PM (2013) Sequences of multiple bacterial genomes and a chlamydia trachomatis genotype from direct sequencing of DNA derived from a vaginal swab diagnostic specimen. Clin Microbiol Infect 19:E405–E408
Joseph SJ, Li B, Ghonasgi T, Haase CP, Qin ZS, Dean D, Read TD (2014) Direct amplification, sequencing and profiling of chlamydia trachomatis strains in single and mixed infection clinical samples. PLoS One. https://doi.org/10.1371/journal.pone.0099290
Wołkowicz T (2017) The utility and perspectives of NGS-based methods in BSL-3 and BSL-4 laboratory – sequencing and analysis strategies. Brief Funct Genomics 17(6):471–476.
Mitchell SL, Mattei LM, Alby K (2017) Whole genome characterization of a naturally occurring vancomycin-dependent Enterococcus faecium from a patient with bacteremia. Infect Genet Evol 52:96–99
Stoesser N, Batty EM, Eyre DW, Morgan M, Wyllie DH, Del Ojo EC, Johnson JR, Walker AS, Peto TEA, Crook DW (2013) Predicting antimicrobial susceptibilities for Escherichia coli and Klebsiella pneumoniae isolates using whole genomic sequence data. J Antimicrob Chemother 68:2234–2244
Sadouki Z, Day MR, Doumith M, Chattaway MA, Dallman TJ, Hopkins KL, Elson R, Woodford N, Godbole G, Jenkins C (2017) Comparison of phenotypic and WGS-derived antimicrobial resistance profiles of Shigella sonnei isolated from cases of diarrhoeal disease in England and Wales, 2015. J Antimicrob Chemother 72:2496–2502
Shelburne SA, Kim J, Munita JM et al (2017) Whole-genome sequencing accurately identifies resistance to extended-spectrum β-lactams for major gram-negative bacterial pathogens. Clin Infect Dis 65:738–745
Bradley P, Gordon NC, Walker TM et al (2015) Rapid antibiotic-resistance predictions from genome sequence data for Staphylococcus aureus and Mycobacterium tuberculosis. Nat Commun. https://doi.org/10.1038/ncomms10063
Jaillard M, van Belkum A, Cady KC et al (2017) Correlation between phenotypic antibiotic susceptibility and the resistome in Pseudomonas aeruginosa. Int J Antimicrob Agents 50:210–218
Zankari E, Hasman H, Kaas RS, Seyfarth AM, Agersø Y, Lund O, Larsen MV, Aarestrup FM (2013) Genotyping using whole-genome sequencing is a realistic alternative to surveillance based on phenotypic antimicrobial susceptibility testing. J Antimicrob Chemother 68:771–777
Zankari E, Hasman H, Cosentino S, Vestergaard M, Rasmussen S, Lund O, Aarestrup FM, Larsen MV (2012) Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother 67:2640–2644
Neuert S, Nair S, Day MR et al (2018) Prediction of phenotypic antimicrobial resistance profiles from whole genome sequences of non-typhoidal Salmonella enterica. Front Microbiol 9:1–11
Gordon NC, Price JR, Cole K et al (2014) Prediction of staphylococcus aureus antimicrobial resistance by whole-genome sequencing. J Clin Microbiol 52:1182–1191
Tyson GH, McDermott PF, Li C et al (2015) WGS accurately predicts antimicrobial resistance in Escherichia coli. J Antimicrob Chemother 70:2763–2769
Mcdermott PF, Tyson GH, Kabera C, Chen Y, Li C, Folster JP, Ayers SL, Lam C, Tate HP (2016) Whole-genome sequencing for detecting antimicrobial resistance in. Antimicrob Agents Chemother 60:5515–5520
Holden MTG, Hsu L, Kurt K et al (2013) A genomic portrait of the emerfences, evolution, and global spread of methicillin-resistant Staphylococcus aureus. Genome Res 23:653–664
Eyre DW, Golubchik T, Gordon NC et al (2012) A pilot study of rapid benchtop sequencing of Staphylococcus aureus and Clostridium difficile for outbreak detection and surveillance. BMJ Open 2:1–9
Hazen TH, Zhao L, Boutin MA, Stancil A, Robinson G, Harris AD, Rasko DA, Johnson JK (2014) Comparative genomics of an IncA/C multidrug resistance plasmid from Escherichia coli and Klebsiella isolates from intensive care unit patients and the utility of whole-genome sequencing in health care settings. Antimicrob Agents Chemother 58:4814–4825
Kos VN, Déraspe M, McLaughlin RE, Whiteaker JD, Roy PH, Alm RA, Corbeil J, Gardner H (2015) The resistome of Pseudomonas seudomonas aeruginosa in relationship to phenotypic susceptibility. Antimicrob Agents Chemother 59:427–436
Luo Y, Luo R, Ding H, Ren X, Luo H, Zhang Y, Ye L, Cui S (2017) Characterization of carbapenem-resistant Escherichia coli isolates through the whole-genome sequencing analysis. Microb Drug Resist 24(2). https://doi.org/10.1089/mdr.2017.0079
Ellington MJ, Ekelund O, Aarestrup FM et al (2017) The role of whole genome sequencing in antimicrobial susceptibility testing of bacteria: report from the EUCAST subcommittee. Clin Microbiol Infect 23:2–22
Xavier BB, Das AJ, Cochrane G, De Ganck S, Kumar-Singh S, Aarestrup FM, Goossens H, Malhotra-Kumar S (2016) Consolidating and exploring antibiotic resistance gene data resources. J Clin Microbiol 54:851–859
McArthur AG, Tsang KK (2017) Antimicrobial resistance surveillance in the genomic age. Ann N Y Acad Sci 1388:78–91
Rowe W, Baker KS, Verner-Jeffreys D, Baker-Austin C, Ryan JJ, Maskell D, Pearce G (2015) Search engine for antimicrobial resistance: a cloud compatible pipeline and web interface for rapidly detecting antimicrobial resistance genes directly from sequence data. PLoS One. https://doi.org/10.1371/journal.pone.0133492
Gupta SK, Padmanabhan BR, Diene SM, Lopez-Rojas R, Kempf M, Landraud L, Rolain JM (2014) ARG-annot, a new bioinformatic tool to discover antibiotic resistance genes in bacterial genomes. Antimicrob Agents Chemother 58:212–220
de Man TJB, Limbago BM (2016) SSTAR, a stand-alone easy-to-use antimicrobial resistance gene predictor. mSphere 1:1–10
Davis JJ, Boisvert S, Brettin T et al (2016) Antimicrobial resistance prediction in PATRIC and RAST. Sci Rep 6:1–12
Brittnacher MJ, Heltshe SL, Hayden HS, Radey MC, Weiss EJ, Damman CJ, Zisman TL, Suskind DL, Miller SI (2016) GUTSS: an alignment-free sequence comparison method for use in human intestinal microbiome and fecal microbiota transplantation analysis. PLoS One 11:1–16
Jia B, Raphenya AR, Alcock B et al (2017) CARD 2017: expansion and model-centric curation of the comprehensive antibiotic resistance database. Nucleic Acids Res 45:D566–D573
Lakin SM, Dean C, Noyes NR et al (2017) MEGARes: an antimicrobial resistance database for high throughput sequencing. Nucleic Acids Res 45:D574–D580
Galagan JE (2014) Genomic insights into tuberculosis. Nat Rev Genet 15:307–320
WHO (2017) Global tunerculosis report 2017. WHO, Geneva
Lange C, Chesov D, Heyckendorf J, Leung CC, Udwadia Z, Dheda K (2018) Drug-resistant tuberculosis: an update on disease burden, diagnosis and treatment. Respirology. https://doi.org/10.1111/resp.13304
McNerney R, Zignol M, Clark TG (2018) Use of whole genome sequencing in surveillance of drug resistant tuberculosis. Expert Rev Anti-Infect Ther 16:433–442
Piersimoni C, Olivieri A, Benacchio L, Scarparo C (2006) MINIREVIEW current perspectives on drug susceptibility testing of Mycobacterium tuberculosis complex : the automated nonradiometric systems. Society 44:20–28
Lange C, Abubakar I, Alffenaar JWC et al (2014) Management of patients with multidrugresistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement. Eur Respir J 44:23–63
Domínguez J, Boettger EC, Cirillo D et al (2016) Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a TBNET/RESIST-TB consensus statement. Int J Tuberc Lung Dis 20:24–42
Feliciano CS, Namburete EI, Rodrigues Plaça J, Peronni K, Dippenaar A, Warren RM, Silva WA, Bollela VR (2018) Accuracy of whole genome sequencing versus phenotypic (MGIT) and commercial molecular tests for detection of drug-resistant Mycobacterium tuberculosis isolated from patients in Brazil and Mozambique. Tuberculosis 110:59–67
Hameed HMA, Islam MM, Chhotaray C et al (2018) Molecular targets related drug resistance mechanisms in MDR-, XDR-, and TDR-Mycobacterium tuberculosis strains. Front Cell Infect Microbiol 8:114
Gillespie S (2002) Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective. Antimicrob Agents Chemother 46:267–274
Miotto P, Tessema B, Tagliani E et al (2017) A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis. Eur Respir J 50(6):1701354. https://doi.org/10.1183/13993003.01354-2017
Walker TM, Kohl TA, Omar SV et al (2015) Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study. Lancet Infect Dis 15:1193–1202
Witney AA, Gould KA, Arnold A et al (2015) Clinical application of whole-genome sequencing to inform treatment for multidrug-resistant tuberculosis cases. J Clin Microbiol 53:1473–1483
Pankhurst LJ, del Ojo EC, Votintseva AA et al (2016) Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective study. Lancet Respir Med 4:49–58
Manson AL, Cohen KA, Abeel T, Desjardins CA, Cho N, Gabrielian A, Gomez J, Jodals AM, Joloba M (2017) HHS Public Access 49:395–402
Coll F, Phelan J, Hill-Cawthorne GA et al (2018) Genome-wide analysis of multi- and extensively drug-resistant Mycobacterium tuberculosis. Nat Genet 50:307–316
Bryant JM, Schürch AC, van Deutekom H et al (2013) Inferring patient to patient transmission of Mycobacterium tuberculosis from whole genome sequencing data. BMC Infect Dis 13:1–12
Glynn JR, Guerra-Assunção JA, Houben RMGJ et al (2015) Whole genome sequencing shows a low proportion of tuberculosis disease is attributable to known close contacts in rural Malawi. PLoS One 10:1–12
Guthrie JL, Delli Pizzi A, Roth D, Kong C, Jorgensen D, Rodrigues M, Tang P, Cook VJ, Johnston J, Gardy JL (2018) Genotyping and whole genome sequencing to identify tuberculosis transmission to Pediatric patients in British Columbia, Canada, 2005–2014. J Infect Dis. https://doi.org/10.1093/infdis/jiy278
Holden KL, Bradley CW, Curran ET, Pollard C, Smith G, Holden E, Glynn P, Garvey MI (2018) Unmasking leading to a healthcare worker Mycobacterium tuberculosis transmission. J Hosp Infect:1–7
Gardy JL, Johnston JC, Sui SJH et al (2011) Whole-genome sequencing and social-network analysis of a tuberculosis outbreak. N Engl J Med 364:730–739
Casali N, Nikolayevskyy V, Balabanova Y et al (2014) Europe PMC Funders Group. Evolution and transmission of drug resistant tuberculosis in a Russian population. Nat Genet 46:279–286
Zeng X, Kwok JS-L, Yang KY, Leung KS-S, Shi M, Yang Z, Yam W-C, Tsui SK-W (2018) Whole genome sequencing data of 1110 Mycobacterium tuberculosis isolates identifies insertions and deletions associated with drug resistance. BMC Genomics 19:365
Zhang H, Li D, Zhao L et al (2013) Genome sequencing of 161 Mycobacterium tuberculosis isolates from China identifies genes and intergenic regions associated with drug resistance. Nat Genet 45:1255–1260
Zignol M, Cabibbe AM, Dean AS et al (2018) Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study. Lancet Infect Dis 18:675–683
Quan TP, Bawa Z, Foster D et al (2017) Evaluation of whole genome sequencing for mycobacterial species identification and drug susceptibility testing in a clinical setting: a large-scale prospective assessment of performance against line-probe assays and phenotyping. J Clin Microbiol 56:JCM.01480-17
Coll F, McNerney R, Preston MD et al (2015) Rapid determination of anti-tuberculosis drug resistance from whole-genome sequences. Genome Med 7:1–10
Chatterjee A, Nilgiriwala K, Saranath D, Rodrigues C, Mistry N (2017) Whole genome sequencing of clinical strains of Mycobacterium tuberculosis from Mumbai, India: a potential tool for determining drug-resistance and strain lineage. Tuberculosis 107:63–72
Votintseva AA, Pankhurst LJ, Anson LW et al (2015) Mycobacterial DNA extraction for whole-genome sequencing from early positive liquid (MGIT) cultures. J Clin Microbiol 53:1137–1143
Brown AC, Bryant JM, Einer-Jensen K et al (2015) Rapid whole-genome sequencing of mycobacterium tuberculosis isolates directly from clinical samples. J Clin Microbiol 53:2230–2237
Cohen T, van Helden PD, Wilson D, Colijn C, McLaughlin MM, Abubakar I, Warren RM (2012) Mixed-strain Mycobacterium tuberculosis infections and the implications for tuberculosis treatment and control. Clin Microbiol Rev 25:708–719
McIvor A, Koornhof H, Kana BD (2017) Relapse, re-infection and mixed infections in tuberculosis disease. Pathog Dis 75:1–16
Macedo R, Nunes A, Portugal I, Duarte S, Vieira L, Gomes JP (2018) Dissecting whole-genome sequencing-based online tools for predicting resistance in Mycobacterium tuberculosis: can we use them for clinical decision guidance? Tuberculosis 110:44–51
Feuerriegel S, Schleusener V, Beckert P, Kohl TA, Miotto P, Cirillo DM, Cabibbe AM, Niemann S, Fellenberg K (2015) PhyResSE: a web tool delineating Mycobacterium tuberculosis antibiotic resistance and lineage from whole-genome sequencing data. J Clin Microbiol 53:1908–1914
Sekizuka T, Yamashita A, Murase Y, Iwamoto T, Mitarai S, Kato S, Kuroda M (2015) TGS-TB: Total genotyping solution for Mycobacterium tuberculosis using short-read whole-genome sequencing. PLoS One 10:1–12
van Beek J, Haanperä M, Smit PW, Mentula S, Soini H (2018) Evaluation of whole genome sequencing and software tools for drug susceptibility testing of Mycobacterium tuberculosis. Clin Microbiol Infect 25(1):82–86. https://doi.org/10.1016/j.cmi.2018.03.041
Cirillo DM, Miotto P, Tortoli E (2017) Evolution of phenotypic and molecular drug susceptibility testing. Adv Exp Med Biol 1019:221–246. https://doi.org/10.1007/978-3-319-64371-7_12
Gcebe N, Rutten VPMG, Van Pittius NG, Naicker B, Michel AL (2018) Mycobacterium komaniense sp. Nov., a rapidly growing nontuberculous Mycobacterium species detected in South Africa. Int J Syst Evol Microbiol 68(5). https://doi.org/10.1099/ijsem.0.002707
Griffith DE, Aksamit T, Brown-Elliott BA et al (2007) An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175:367–416
Prevots DR, Marras TK (2015) Epidemiology of human pulmonary infection with non- tuberculous mycobacteria: a review. Clin Chest Med 36:13–34
van Ingen J (2015) Microbiological diagnosis of nontuberculous mycobacterial pulmonary disease. Clin Chest Med 36:43–54
Somoskovi A, Salfinger M (2014) Nontuberculous mycobacteria in respiratory infections: advances in diagnosis and identification. Clin Lab Med 34:271–295
Tortoli E (2014) Microbiological features and clinical relevance of new species of the genus Mycobacterium. Clin Microbiol Rev 27:727–752
Koh W-J (2017) Nontuberculous mycobacteria—overview. Microbiol Spectr 5(1). https://doi.org/10.1128/microbiolspec.tnmi7-0024-2016
Olaru ID, Patel H, Kranzer K, Perera N (2018) Turnaround time of whole genome sequencing for mycobacterial identification and drug susceptibility testing in routine practice. Clin Microbiol Infect 24:659.e5–659.e7
Shea J, Halse TA, Lapierre P, Shudt M, Kohlerschmidt D, Van Roey P, Limberger R, Taylor J, Escuyer V, Musser KA (2017) Comprehensive whole-genome sequencing and reporting of drug resistance profiles on clinical cases of Mycobacterium tuberculosis in New York. J Clin Microbiol 55:1871–1882
Votintseva AA, Bradley P, Pankhurst L et al (2017) Same-day diagnostic and surveillance data for tuberculosis via whole-genome sequencing of direct respiratory samples. J Clin Microbiol 55:1285–1298
Cabibbe AM, Trovato A, De Filippo MR et al (2018) Early View Countrywide implementation of whole genome sequencing : an opportunity to improve tuberculosis management, surveillance and contact tracing in low incidence countries. Eur Respir J. https://doi.org/10.1183/13993003.00387-2018
Stefani MMA, Avanzi C, Bührer-Sékula S et al (2017) Whole genome sequencing distinguishes between relapse and reinfection in recurrent leprosy cases. PLoS Negl Trop Dis 11:1–13
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Vourli, S., Kontos, F., Pournaras, S. (2021). WGS for Bacterial Identification and Susceptibility Testing in the Clinical Lab. In: Moran-Gilad, J., Yagel, Y. (eds) Application and Integration of Omics-powered Diagnostics in Clinical and Public Health Microbiology . Springer, Cham. https://doi.org/10.1007/978-3-030-62155-1_3
Download citation
DOI: https://doi.org/10.1007/978-3-030-62155-1_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-62154-4
Online ISBN: 978-3-030-62155-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)